Pediatric Infectious Diseases Physicians’ Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network Survey

Journal of the Pediatric Infectious Diseases Society 2026

View at publisher
Authors: Alexandra Linn, Noah Boton, Susan E. Beekmann, Larry K. Kociolek, Thomas J. Sandora, Philip M. Polgreen, Matthew Shou Lun Lee, Preeti Mehrotra
DOI: 10.1093/jpids/piag004
Cited by: 0
References: 11

Abstract

We queried pediatric infectious diseases physicians via the Emerging Infections Network regarding management preferences for Clostridioides difficile infection (CDI). We explored use of vancomycin, fidaxomicin, bezlotoxumab, and fecal microbiota transplantation and found that physicians are increasingly considering newer and adjunctive therapies for pediatric CDI, highlighting the need for updated guidelines.

Fields of Study & Subjects

Clostridium difficile and Clostridium perfringens research Antibiotic Use and Resistance Bacterial Identification and Susceptibility Testing

Publication details

Journal / source
Journal of the Pediatric Infectious Diseases Society
Volume
15
Issue
1
Publication date
1 January 2026
Language
EN